Bp PLC Biogen Inc. Transaction History

Bp PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $985,937 - $1.29 Million	-3,484 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$259.0 - $414.71 $377,881 - $605,061	-1,459 Reduced 29.52%	3,484 $1.21 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $277,934 - $325,616	-1,144 Reduced 18.79%	4,943 $1.38 Million
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $1.75 Million - $2.63 Million	-7,402 Reduced 54.87%	6,087 $1.49 Million
Q3 2020 Oct 30, 2020	SELL	$264.77 - $305.71 $903,130 - $1.04 Million	-3,411 Reduced 20.18%	13,489 $3.82 Million
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $801,846 - $1.06 Million	-3,100 Reduced 15.5%	16,900 $4.52 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $650,130 - $1.02 Million	-3,000 Reduced 13.04%	20,000 $4.73 Million
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $2.23 Million - $2.82 Million	-8,000 Reduced 25.81%	23,000 $6.92 Million
Q3 2018 Nov 02, 2018	BUY	$293.51 - $383.83 $1.58 Million - $2.07 Million	5,400 Added 21.09%	31,000 $11 Million
Q2 2018 Jul 30, 2018	BUY	$257.52 - $306.91 $412,032 - $491,056	1,600 Added 6.67%	25,600 $7.43 Million
Q4 2017 Feb 06, 2018	SELL	$307.64 - $344.58 $7.38 Million - $8.27 Million	-24,000 Reduced 50.0%	24,000 $7.65 Million
Q3 2017 Oct 30, 2017	BUY	$281.15 - $329.69 $13.5 Million - $15.8 Million	48,000	48,000 $15 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.